Patents by Inventor Kathleen Börner

Kathleen Börner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified AAV Capsid Proteins for Treatment of Arthritic Disease
    Publication number: 20220267797
    Abstract: The invention relates to recombinant adeno-associated virus (rAAV) virions for gene therapy, wherein the rAAV virions comprise a novel capsid protein. In particular, the invention relates to the use of such virions in gene therapy for the treatment of an arthritic disease, such as for example rheumatoid arthritis, or symptoms thereof, preferably by intraarticular administration.
    Type: Application
    Filed: July 15, 2020
    Publication date: August 25, 2022
    Inventors: Sabine Maria Gertrude Van Der Sanden, Susanne Anna Snoek, Niels Broekstra, Jonathan Douglas Finn, Dirk Grimm, Kathleen Börner
  • MODIFIED RAAV CAPSID PROTEIN FOR GENE THERAPY
    Publication number: 20200354744
    Abstract: The invention relates to recombinant adeno-associated virus (rAAV) virions for gene therapy, wherein the rAAV virions comprise a novel capsid protein. In particular, the invention relates to the use of such virions in gene therapy for the treatment of an arthritic disease, such as for example rheumatoid arthritis, or symptoms thereof, preferably by intraarticular administration.
    Type: Application
    Filed: January 17, 2019
    Publication date: November 12, 2020
    Inventors: Jonathan Douglas Finn, Dirk Grimm, Kathleen Börner, Niels Broekstra, Susanne Anna Snoek, Sabine Maria Gertrude Van Der Sanden